593 related articles for article (PubMed ID: 17534636)
1. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
[TBL] [Abstract][Full Text] [Related]
2. Detection of pemphigus autoantibodies by IIF and ELISA tests in patients with pemphigus vulgaris and foliaceus and in healthy relatives.
Torzecka JD; Narbutt J; Sysa-Jedrzejowska A; Waszczykowska E; Lukamowicz J; Pas HH
Med Sci Monit; 2003 Dec; 9(12):CR528-33. PubMed ID: 14646976
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
Green MG; Bystryn JC
Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
[TBL] [Abstract][Full Text] [Related]
4. Determination of IgG subclasses in patients with pemphigus with active disease and in remission.
David M; Katzenelson V; Hazaz B; Ben-Chetrit A; Sandbank M
Arch Dermatol; 1989 Jun; 125(6):787-90. PubMed ID: 2658844
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulin G subclass distribution of anti-intercellular substance antibodies in pemphigus].
Trémeau-Martinage C; Oksman F; Bazex J
Ann Dermatol Venereol; 1995; 122(6-7):409-11. PubMed ID: 8526422
[TBL] [Abstract][Full Text] [Related]
6. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
[TBL] [Abstract][Full Text] [Related]
7. Case of pemphigus with immunoglobulin G and A antibodies, binding to both the intercellular spaces and basement membrane zone.
Hosoda S; Adachi A; Suzuki M; Yamada T; Komine M; Murata S; Ohtsuki M
J Dermatol; 2016 Feb; 43(2):194-6. PubMed ID: 26219735
[TBL] [Abstract][Full Text] [Related]
8. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia.
Abida O; Kallel-Sellami M; Joly P; Ben Ayed M; Zitouni M; Masmoudi A; Mokni M; Fezzaa B; Ben Osman A; Kammoun MR; Gilbert D; Turki H; Tron F; Masmoudi H; Makni S;
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1073-8. PubMed ID: 19453789
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes.
Kim YH; Geoghegan WD; Jordon RE
J Lab Clin Med; 1990 Mar; 115(3):324-31. PubMed ID: 2179435
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the nature and pathogenicity of circulating antikeratinocyte antibodies in dogs with pemphigus foliaceus.
Olivry T; Dunston SM; Walker RH; Alhaidari Z; Messinger L; Liu Z
Vet Dermatol; 2009 Feb; 20(1):42-50. PubMed ID: 19152586
[TBL] [Abstract][Full Text] [Related]
12. Screening and analysis of adsorbents for pemphigus autoantibodies.
Yamada H; Itoh A; Hatanaka Y; Tsukiji M; Takamori K
Ther Apher Dial; 2010 Jun; 14(3):292-7. PubMed ID: 20609181
[TBL] [Abstract][Full Text] [Related]
13. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
Rigopoulou EI; Davies ET; Bogdanos DP; Liaskos C; Mytilinaiou M; Koukoulis GK; Dalekos GN; Vergani D
Liver Int; 2007 Nov; 27(9):1226-31. PubMed ID: 17919234
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
15. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
Kwon EJ; Yamagami J; Nishikawa T; Amagai M
J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
[TBL] [Abstract][Full Text] [Related]
16. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
[TBL] [Abstract][Full Text] [Related]
17. Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients.
Calvanico NJ; Swartz SJ; Diaz LA
J Autoimmun; 1993 Apr; 6(2):145-57. PubMed ID: 8499057
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus.
Czernik A; Beutner EH; Bystryn JC
J Am Acad Dermatol; 2008 May; 58(5):796-801. PubMed ID: 18423257
[TBL] [Abstract][Full Text] [Related]
19. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
[TBL] [Abstract][Full Text] [Related]
20. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
Eming R; Rech J; Barth S; Kalden JR; Schuler G; Harrer T; Hertl M
Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
